The effect of an NO donor, pentaerythrityl tetranitrate, on biochemical, functional, and morphological attributes of cardiovascular system of spontaneously hypertensive rats

General Physiology and Biophysics

Volumn 28, Issue 1, 2009, Pages 86-93

  Dovinová, Ima ^a   Cačáanyiová, Sonňa ^a   Fáberová, Viera ^b   Kristek, František ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b Drug Research Institute   (Slovakia)

Author keywords

Antioxidant enzyme activity; Cardiovascular system; NO donor; Spontaneously hypersensitive rat; Vasoreactivity and morphometry

Indexed keywords

ACETYLCHOLINE; CATALASE; CYCLIC GMP; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NITRIC OXIDE; NITRIC OXIDE DONOR; NORADRENALIN; PENTAERYTHRITYL TETRANITRATE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCHEMISTRY; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL DIAMETER; BLOOD VESSEL WALL; CARDIOVASCULAR EFFECT; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; HEART VENTRICLE HYPERTROPHY; ILIAC ARTERY; MALE; MORPHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; THROMBOCYTE; TREATMENT DURATION; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

ACETYLCHOLINE; ANIMALS; AORTA; BLOOD PRESSURE; CYCLIC GMP; GLUTATHIONE PEROXIDASE; HEART; HYPERTENSION; ILIAC ARTERY; MALE; MYOCARDIUM; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NOREPINEPHRINE; PENTAERYTHRITOL TETRANITRATE; RATS; RATS, INBRED SHR; RATS, WISTAR; SUPEROXIDE DISMUTASE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

RATTUS; RATTUS NORVEGICUS;

EID: 65349125930     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: 10.4149/gpb_2009_01_86     Document Type: Article

References (39)

1. Aebi H. (1984): Catalase in vitro. Methods Enzymol. 105, 125-126
2. Arnal J. F., Yamin J., Dockery S., Harrison D. G. (1994): Regulation of endothelial nitric oxide synthase mRNA, protein, and activity during cell growth. Am. J. Physiol., Cell Physiol. 267, C1381-388
3. Bird R. P., Drapper H. H., Valli V. E. (1982): Toxicological evaluation of malondialdehyde: a 12-month study of mice. J. Toxicol. Environ. Health 10, 897-905
4. Brendt D. S., Snyder S. H. (1990): Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. U.S.A. 87, 682-685
5. Bult H., DeMeyer G. R. Y., Jordaens F. H., Herman A. G. (1991): Chronic exposure to exogenous nitric oxide may suppress its endogenous release and efficacy. J. Cardiovasc. Pharmacol. 17 (Suppl. 3), S79-82
6. Čačányiová S., Cebová M., Kuneš J., Kristek F. (2006): Comparison of vascular function and structure of iliac artery in spontaneously hypertensive and hereditaryhypertriglyceridemic rats. Physiol. Res. 55 (Suppl. 1), S73-80
7. Corriu C., Félétou M., Canet E., Vanhoutte P. M. (1996): Endothelium-derived factors and hyperpolarization of the carotid artery of guinea-pig. Br. J. Pharmacol. 119, 959-964
8. Csonka C., Pataki T., Kovacs P., Muller S. L., Schroeter M. L., Tosaki A., Blasig I. E. (2000): Effects of oxidative stress on the expression of antioxidative defense enzymes in spontaneously hypertensive rat hearts. Free Radic. Biol. Med. 29, 612-619
9. DeMey J. G., Gray S. (1985): Endothelium-dependent reactivity in resistance vessels. Prog. Appl. Microcirc. 8, 181-187
10. Dröge W. (2002): Free radicals in the physiological control of cell function. Physiol. Rev. 82, 47-95
11. 2+ channel in chronic alcoholic subjects without cardiomyopathy. Alcohol. Clin. Exp. Res. 31, 1099-1105
12. Fink B., Bassenge E. (1997): Unexpected, tolerance-devoid vasomotor and platelet actions of pentaerythrityl tetranitrate. J. Cardiovasc. Pharmacol. 30, 831-836
13. Gerová M., Török J., Pecháňová, O., Matušková, J. (2004): Rilmenidine prevents blood pressure increase in rats with compromised nitric oxide production. Acta Pharmacol. Sin. 25, 1640-1646
14. Gerová M., Kristek F., Čačányiová S., Cebová M. (2005): Acetylcholine and bradykinin enhance hypotension and affect the function of remodeled conduit arteries in SHR and SHR treated with nitric oxide donors. Braz. J. Med. Biol. Res. 38, 959-966
15. Gerová M., Kittová M. (2006): Systemic blood pressure response to the inhibition of two hyperpolarizing pathways: a comparison to NO-synthase inhibition. Physiol. Res. 55, 603-610
16. Hacker A., Müller S., Meyer W., Kojda G. (2001): The nitric oxide donor pentaerythritol tetranitrate can preserve endothelial function in established atherosclerosis. Br. J. Pharmacol. 132, 1707-1714
17. Hinz B., Kuntze U., Schröder H. (1998): Pentaerithrityl tetranitrate and its phase I metabolites are potent activators of cellular cyclic GMP accumulation. Biochem. Biophys. Res. Commun. 253, 658-661
18. Janega P., Kojšová S., Jendeková L., Babál P., Pecháňová O. (2007): Indapamide-induced prevention of myocardial fibrosis in spontaneous hypertension rats is not nitric oxide-related. Physiol. Res. 56, 825-828
19. Kristek F. (2000): Pentaerythrityl tetranitrate could prevent structural changes in conduit arteries evoked by long-term NO-synthase inhibition. Br. J. Pharmacol. 130, 450-456
20. Kristek F., Fáberová V., Varga I. (2003): Long-term effect of molsidomine and pentaerythrityl tetranitrate on cardiovascular system of spontaneously hypertensive rats. Physiol. Res. 52, 709-717
21. Lüscher T. F. (1990): The endothelium: target and promoter of hypertension? Hypertension 15, 482-485
22. Malinski T., Kapturczak M., Dayharsh J., Bohr D. (1993): Nitric oxide synthase activity in genetic hypertension. Biochem. Biophys. Res. Commun. 194, 654-568
23. Minami N., Imai Y., Hashimoto J., Abe K. (1995): Contribution of nitric oxide to basal blood pressure in concious spontaneously hypertensive rats and normotensive Wistar Kyoto rats. Clin. Sci. 89, 177-182
24. Mollnau H., Oelze M., August M., Wendt M., Daiber A., Schulz E., Baldus S., Kleschyov A. L., Materne A., Wenzel P., Hink U., Nickenig G., Fleming I., Munzel T. (2005): Mechanisms of increased vascular superoxide production in an experimental model of idiopathic dilated cardiomyopathy. Arterioscler. Thromb. Vasc. Biol. 25, 2554-2559
25. Mourlon-Le Grand M. C., Benessiano J., Levy B. I. (1992): cGMP pathway and mechanical properties of carotid artery wall in WKY rats and SHR: role of endothelium. Am. J. Physiol., Heart Circ. Physiol. 263, H61-67
26. Oberle S., Abate A., Grosser N., Hemmerle A., Vreman H. J., Dennery P. A., Heinz T., Schneider H. T., Stalleicken D., Schroder H. (2003): Endothelial protection by pentaerithrityltrinitrate: bilirubin and carbon monoxide as possible mediators. Exp. Biol. Med. 228, 529-534
27. Papapetropoulos A., Marczin N., Snead M. D., Cheng C., Milici A., Cantravas J. D. (1994): Smooth muscle responsiveness to nitrovasodilators in hypertensive and normotensive rats. Hypertension 23, 76-484
28. Paravicini T. M., Touyz R. M. (2006): Redox signaling in hypertension (Review). Cardiovasc. Res. 71, 147-158
29. Pourageaud F., Freslon J. L. (1995): Endothelial smooth muscle properties of coronary and mesenteric resistance arteries in spontaneously hypertensive rats compared to WKY rats. Fundam. Clin. Pharmacol. 9, 37-45
30. Racasan S., Braam B., Koomans H. A., Joles J. A. (2005): Programming blood pressure in adult SHR by shifting perinatal balance of NO and reactive oxygen species toward NO: the inverted Barker phenomenon. Am. J. Physiol., Renal Physiol. 288, R626-636
31. Rao G. M. (1981): Effect of genetic diabetes on β-N-acetylglu-cosaminidase activity in plasma, conjunctiva, muscle and kidney cortex in mice. Biomedicine 35, 159-161
32. Rengasamy A., Johns R. A. (1993): Regulation of nitric oxide synthase by nitric oxide. Mol. Pharmacol. 44, 124-128
33. Stephens J. W., Khanolkar M. P., Bain S. C. (2008): The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 202, 321-329
34. Török J., Kristek F. (2002): Beneficial effect of pentaerythrityl tetranitrate on functional and morphological changes in the rat thoracic aorta evoked by long-term nitric oxide synthase inhibition. Vascul. Pharmacol. 38, 177-182
35. Tschudi M., Crisciona L., Novosel D., Pfeiffer K., Lüscher T. (1994): Antihypertensive therapy augments endothelium-dependent relaxations in coronary arteries of spontaneously hypertensive rats. Circulation 98, 2212-2218
36. Ulker S., McMaster D., McKeown P. P., Bayraktutan U. (2003): Impaired activities of antioxidant enzymes elicit endothelial dysfunction in spontaneous hypertensive rats despite enhanced vascular nitric oxide generation. Cardiovasc. Res. 59, 488-500
37. Weber W., Michaelis K., Luckow V., Kuntze U., Stalleicken D. (1995): Pharmacokinetics and bioavailability of pentaerithrityl tetranitrate and two of its metabolites. Arzneimittelforschung 45, 781-784
38. Yanes L., Romero D., Iliescu R., Cucchiarelli V. E., Fortepiani L. A., Santacruz F., Bell W., Zhang H., Reckelhoff J. F. (2005): Systemic arterial pressure response to two weeks of Tempol therapy in SHR: involvement of NO, the RAS, and oxidative stress. Am. J. Physiol., Regul. Integr. Comp. Physiol. 288, R903-908
39. Zalba G., Jose G. S., Moreno M. U., Fortuno M. A., Fortuno A., Beaumont F. J., Diez J. (2001): Oxidative stress in arterial hypertension - role of NAD(P)H oxidase. Hypertension 38, 1395-1399